Dihydropyridine Calcium Antagonist‐Induced Modulation of Endothelial Function: A Review
Authors:
- 7 June 1999
- journal article
- review article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 17 (2) , 179-186
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Current status of calcium channel blockersCurrent Problems in Cardiology, 1994
- Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.Hypertension, 1994
- Comparative effects of the Dihydropyridine-type calcium-agonists (−)-S-Bay K 8644, (±)-Bay-W 5035 and (±)-Bay-T 5006 on human platelet aggregabilityGeneral Pharmacology: The Vascular System, 1994
- Experimental Vasoprotection by Calcium Antagonists Against Calcium-Mediated Arteriosclerotic AlterationsJournal of Cardiovascular Pharmacology, 1994
- Reduced responses of nitrendipine in PGF2α-precontracted porcine isolated arteries after pretreatment with methylene blueBasic Research in Cardiology, 1990
- Influence of nifedipine on experimental arteriosclerosisCardiovascular Drugs and Therapy, 1990
- Retardation of angiographic progression of coronary artery disease by nifedipineThe Lancet, 1990
- Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cellsBiochemical and Biophysical Research Communications, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980